Skip to main content
Top
Published in: Clinical Reviews in Allergy & Immunology 1/2014

01-02-2014

Volatile Substance Misuse: An Updated Review of Toxicity and Treatment

Authors: Jonathan B. Ford, Mark E. Sutter, Kelly P. Owen, Timothy E. Albertson

Published in: Clinical Reviews in Allergy & Immunology | Issue 1/2014

Login to get access

Abstract

Educational campaigns and legislative actions may have led to an overall decrease in the prevalence of volatile substance misuse (VSM) in many countries; however, it is still a common practice throughout the world. Studies currently suggest that girls are misusing volatile substances more than before and at a prevalence rate equal to or exceeding that of boys in several countries. Products that may be misused are ubiquitous and relatively easy to acquire. The most commonly misused substances in recent studies are fuels such as butane or petrol and compressed gas dusters and deodorants that may contain fluorocarbons and/or butane. Detection of VSM is challenging, therefore physicians must maintain a high level of suspicion based on history and clinical presentation. Clues to misuse are often subtle and may include the patient's proximity to a volatile substance or paraphernalia when found intoxicated, dermal burns, blisters, pigments, or rashes, and chemical odors. The primary targets of toxicity are the brain and the heart. The leading cause of death from VSM is from ventricular dysrhythmias. Treatment of toxicity begins with support of airway, breathing, and circulation. Exogenous catecholamines should be avoided if possible due to the theoretical “sensitized” and irritable myocardium. In the case of ventricular dysrhythmias, direct current defibrillation and/or beta-adrenergic receptor antagonism should be used. New evidence demonstrates the addictive potential of VSM yet effective therapy remains uncertain. Further research is needed in developing methods for preventing, detecting, and treating the harmful effects of VSM.
Literature
1.
go back to reference Marelich GP (1997) Volatile substance abuse. Clin Rev Allergy Immunol 15:271–289PubMed Marelich GP (1997) Volatile substance abuse. Clin Rev Allergy Immunol 15:271–289PubMed
2.
go back to reference Johnston LD, O”Malley PM, Bachman JG, Schulenberg JE (2012) Table 2 Trends in Annual Prevalence of Use of Various Drugs in Grades 8, 10, and 12. The Monitoring the Future study, the University of Michigan. Retrieved February 12, 2013 from http://www.monitoringthefuture.org Johnston LD, O”Malley PM, Bachman JG, Schulenberg JE (2012) Table 2 Trends in Annual Prevalence of Use of Various Drugs in Grades 8, 10, and 12. The Monitoring the Future study, the University of Michigan. Retrieved February 12, 2013 from http://​www.​monitoringthefut​ure.​org
6.
go back to reference Villatoro JA, Cruz SL, Ortiz A, Medina-Mora ME (2011) Volatile substance misuse in Mexico: correlates and trends. Subst Use Misuse 46(Suppl 1):40–45PubMed Villatoro JA, Cruz SL, Ortiz A, Medina-Mora ME (2011) Volatile substance misuse in Mexico: correlates and trends. Subst Use Misuse 46(Suppl 1):40–45PubMed
7.
go back to reference Neumark Y, Bar-Hamburger R (2011) Volatile substance misuse among youth in Israel: results of a national school survey. Subst Use Misuse 46(Suppl 1):21–26PubMed Neumark Y, Bar-Hamburger R (2011) Volatile substance misuse among youth in Israel: results of a national school survey. Subst Use Misuse 46(Suppl 1):21–26PubMed
9.
go back to reference Johnston L, O”Malley PM, Bachman JG, Schulenberg JE (2012) Monitoring the Future national survey results on drug use, 1975–2011. Volume I: Secondary school students. Ann Arbor: Institue for Social Research, The University of Michigan. Retrieved February 12, 2013 from http://www.monitoringthefuture.org/pubs.html Johnston L, O”Malley PM, Bachman JG, Schulenberg JE (2012) Monitoring the Future national survey results on drug use, 1975–2011. Volume I: Secondary school students. Ann Arbor: Institue for Social Research, The University of Michigan. Retrieved February 12, 2013 from http://​www.​monitoringthefut​ure.​org/​pubs.​html
10.
go back to reference Butland BK, Field-Smith ME, Ramsey JD, Anderson HR (2012) Twenty-five years of volatile substance abuse mortality: a national mortality surveillance programme. Addiction 108:385–393PubMed Butland BK, Field-Smith ME, Ramsey JD, Anderson HR (2012) Twenty-five years of volatile substance abuse mortality: a national mortality surveillance programme. Addiction 108:385–393PubMed
11.
go back to reference Spiller H, Lorenz DJ (2009) Trends in volatile substance abuse. J Addict Dis 28:164–170PubMed Spiller H, Lorenz DJ (2009) Trends in volatile substance abuse. J Addict Dis 28:164–170PubMed
12.
go back to reference Dell D, Hopkins C (2011) Residential volatile substance misuse treatment for indigenous youth in Canada. Substance Use & Misuse 46:107–113 Dell D, Hopkins C (2011) Residential volatile substance misuse treatment for indigenous youth in Canada. Substance Use & Misuse 46:107–113
13.
go back to reference Wallace EA, Green AS (2009) Methanol toxicity secondary to inhalant abuse in adult men. Clin Toxicol 47:239–242 Wallace EA, Green AS (2009) Methanol toxicity secondary to inhalant abuse in adult men. Clin Toxicol 47:239–242
14.
go back to reference LoVecchio F, Sawyers B, Thole D, Beuler MC, Winchell J, Curry SC (2004) Outcomes following abuse of methanol-containing carburetor cleaners. Hum Exp Toxicol 23:473–475PubMed LoVecchio F, Sawyers B, Thole D, Beuler MC, Winchell J, Curry SC (2004) Outcomes following abuse of methanol-containing carburetor cleaners. Hum Exp Toxicol 23:473–475PubMed
15.
go back to reference Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC (2012) 2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol 50:911–1164 Bronstein AC, Spyker DA, Cantilena LR Jr, Rumack BH, Dart RC (2012) 2011 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 29th Annual Report. Clin Toxicol 50:911–1164
16.
go back to reference Marsolek MR, White NC, Litovitz TL (2010) Inhalant abuse: monitoring trends by using poison control data, 1993–2008. Pediatrics 125:906–913PubMed Marsolek MR, White NC, Litovitz TL (2010) Inhalant abuse: monitoring trends by using poison control data, 1993–2008. Pediatrics 125:906–913PubMed
17.
go back to reference Avella J, Kunaparaju N, Kumar S, Lehrer M, Zito SW, Barletta M (2010) Uptake and distribution of the abused inhalant 1,1-difluoroethane in the rat. J Anal Toxicol 34:381–388PubMed Avella J, Kunaparaju N, Kumar S, Lehrer M, Zito SW, Barletta M (2010) Uptake and distribution of the abused inhalant 1,1-difluoroethane in the rat. J Anal Toxicol 34:381–388PubMed
18.
go back to reference Pegg DG, Zempel JA, Braun WH, Watanabe PG (1979) Disposition of tetrachloro(14C)ethylene following oral and inhalation exposure in rats. Toxicol Appl Pharmacol 51:465–474PubMed Pegg DG, Zempel JA, Braun WH, Watanabe PG (1979) Disposition of tetrachloro(14C)ethylene following oral and inhalation exposure in rats. Toxicol Appl Pharmacol 51:465–474PubMed
19.
go back to reference Omar SA, Artime E, Webb AJ (2012) A comparison of organic and inorganic nitrates/nitrites. Nitric Oxide: Biol Chem 26:229–240 Omar SA, Artime E, Webb AJ (2012) A comparison of organic and inorganic nitrates/nitrites. Nitric Oxide: Biol Chem 26:229–240
20.
go back to reference Löf A, Wigaeus Hjelm E, Colmsjö A, Lundmark BO, Norström A, Sato A (1993) Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene. Br J Ind Med 50:55–59PubMedCentralPubMed Löf A, Wigaeus Hjelm E, Colmsjö A, Lundmark BO, Norström A, Sato A (1993) Toxicokinetics of toluene and urinary excretion of hippuric acid after human exposure to 2H8-toluene. Br J Ind Med 50:55–59PubMedCentralPubMed
21.
go back to reference Tsukamoto S, Chiba S, Muto T, Ishikawa T, Shimamura M (1985) Study on the metabolism of volatile hydrocarbons in mice—propane, n-butane, and iso-butane. J Toxicol Sci 10:323–332PubMed Tsukamoto S, Chiba S, Muto T, Ishikawa T, Shimamura M (1985) Study on the metabolism of volatile hydrocarbons in mice—propane, n-butane, and iso-butane. J Toxicol Sci 10:323–332PubMed
22.
go back to reference Needleman P (1976) Organic nitrate metabolism. Annu Rev Pharmacol Toxicol 16:81–93PubMed Needleman P (1976) Organic nitrate metabolism. Annu Rev Pharmacol Toxicol 16:81–93PubMed
23.
go back to reference Wennmalm A, Benthin G, Edlund A et al (1993) Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73:1121–1127PubMed Wennmalm A, Benthin G, Edlund A et al (1993) Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res 73:1121–1127PubMed
26.
go back to reference MacLean SJ, D”abbs PH (2011) Five challenges for volatile substance misuse policy and intervention in Australia. Drug Alcohol Rev 30:223–227PubMed MacLean SJ, D”abbs PH (2011) Five challenges for volatile substance misuse policy and intervention in Australia. Drug Alcohol Rev 30:223–227PubMed
27.
go back to reference Bowen SE, Batis JC, Paez-Martinez N, Cruz SL (2006) The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 28:636–647PubMed Bowen SE, Batis JC, Paez-Martinez N, Cruz SL (2006) The last decade of solvent research in animal models of abuse: mechanistic and behavioral studies. Neurotoxicol Teratol 28:636–647PubMed
28.
go back to reference Cruz SL, Gauthereau MY, Camacho-Munoz C, Lopez-Rubalcava C, Balster RL (2003) Effects of inhaled toluene and 1,1,1-trichloroethane on seizures and death produced by N-methyl-d-aspartic acid in mice. Behav Brain Res 140:195–202PubMed Cruz SL, Gauthereau MY, Camacho-Munoz C, Lopez-Rubalcava C, Balster RL (2003) Effects of inhaled toluene and 1,1,1-trichloroethane on seizures and death produced by N-methyl-d-aspartic acid in mice. Behav Brain Res 140:195–202PubMed
29.
go back to reference Lopreato GF, Phelan R, Borghese CM, Beckstead MJ, Mihic SJ (2003) Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend 70:11–15PubMed Lopreato GF, Phelan R, Borghese CM, Beckstead MJ, Mihic SJ (2003) Inhaled drugs of abuse enhance serotonin-3 receptor function. Drug Alcohol Depend 70:11–15PubMed
30.
go back to reference Beckstead MJ, Weiner JL, Eger EI 2nd, Gong DH, Mihic SJ (2000) Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 57:1199–1205PubMed Beckstead MJ, Weiner JL, Eger EI 2nd, Gong DH, Mihic SJ (2000) Glycine and gamma-aminobutyric acid(A) receptor function is enhanced by inhaled drugs of abuse. Mol Pharmacol 57:1199–1205PubMed
31.
go back to reference Stengard K, Hoglund G, Ungerstedt U (1994) Extracellular dopamine levels within the striatum increase during inhalation exposure to toluene: a microdialysis study in awake, freely moving rats. Toxicol Lett 71:245–255PubMed Stengard K, Hoglund G, Ungerstedt U (1994) Extracellular dopamine levels within the striatum increase during inhalation exposure to toluene: a microdialysis study in awake, freely moving rats. Toxicol Lett 71:245–255PubMed
32.
go back to reference Gerasimov MR, Schiffer WK, Marstellar D, Ferrieri R, Alexoff D, Dewey SL (2002) Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 65:243–251PubMed Gerasimov MR, Schiffer WK, Marstellar D, Ferrieri R, Alexoff D, Dewey SL (2002) Toluene inhalation produces regionally specific changes in extracellular dopamine. Drug Alcohol Depend 65:243–251PubMed
33.
go back to reference Riegel AC, Zapata A, Shippenberg TS, French ED (2007) The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology 32:1558–1569PubMed Riegel AC, Zapata A, Shippenberg TS, French ED (2007) The abused inhalant toluene increases dopamine release in the nucleus accumbens by directly stimulating ventral tegmental area neurons. Neuropsychopharmacology 32:1558–1569PubMed
34.
go back to reference Funada M, Sato M, Zhou X, Kanai H, Wada K (2005) Neuroadaptive mechanisms form development of psychological dependence on volatile organic solvents. Japan J Psychopharm 25:1–9 Funada M, Sato M, Zhou X, Kanai H, Wada K (2005) Neuroadaptive mechanisms form development of psychological dependence on volatile organic solvents. Japan J Psychopharm 25:1–9
35.
go back to reference Perron BE, Howard MO, Vaughn MG, Jarman CN (2009) Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder. Med Hypotheses 73:935–937PubMedCentralPubMed Perron BE, Howard MO, Vaughn MG, Jarman CN (2009) Inhalant withdrawal as a clinically significant feature of inhalant dependence disorder. Med Hypotheses 73:935–937PubMedCentralPubMed
36.
go back to reference Kouzoupis AV, Konstantakopoulos G, Oulis P, Kalfakis N, Papageorgiou SG (2010) A case of severe toluene withdrawal syndrome treated with clonazepam. J Neuropsychiatr Clin Neurosci 22:E16–E17 Kouzoupis AV, Konstantakopoulos G, Oulis P, Kalfakis N, Papageorgiou SG (2010) A case of severe toluene withdrawal syndrome treated with clonazepam. J Neuropsychiatr Clin Neurosci 22:E16–E17
37.
go back to reference Papageorgiou SG, Karantoni E, Pandis D, Kouzoupis AV, Kalfakis N, Limouris GS (2009) Severe dopaminergic pathways damage in a case of chronic toluene abuse. Clin Neurol Neurosurg 11:864–867 Papageorgiou SG, Karantoni E, Pandis D, Kouzoupis AV, Kalfakis N, Limouris GS (2009) Severe dopaminergic pathways damage in a case of chronic toluene abuse. Clin Neurol Neurosurg 11:864–867
38.
go back to reference Grosse K, Grosse J (2000) Propane abuse. Extreme dose increase due to development of tolerance. Der Nervenarzt 71:50–53PubMed Grosse K, Grosse J (2000) Propane abuse. Extreme dose increase due to development of tolerance. Der Nervenarzt 71:50–53PubMed
39.
go back to reference Cruz SL, Dominguez M (2011) Misusing volatile substances for their hallucinatory effects: a qualitative pilot study with Mexican teenagers and a pharmacological discussion of their hallucinations. Subst Use Misuse 46(Suppl 1):84–94PubMed Cruz SL, Dominguez M (2011) Misusing volatile substances for their hallucinatory effects: a qualitative pilot study with Mexican teenagers and a pharmacological discussion of their hallucinations. Subst Use Misuse 46(Suppl 1):84–94PubMed
40.
go back to reference Broussard LA, Brustowicz T, Pittman T, Atkins KD, Presley L (1997) Two traffic fatalities related to the use of difluoroethane. J Forensic Sci 42:1186–1187PubMed Broussard LA, Brustowicz T, Pittman T, Atkins KD, Presley L (1997) Two traffic fatalities related to the use of difluoroethane. J Forensic Sci 42:1186–1187PubMed
41.
go back to reference Hahn T, Avella J, Lehrer M (2006) A motor vehicle accident fatality involving the inhalation of 1,1-difluoroethane. J Anal Toxicol 30:638–642PubMed Hahn T, Avella J, Lehrer M (2006) A motor vehicle accident fatality involving the inhalation of 1,1-difluoroethane. J Anal Toxicol 30:638–642PubMed
42.
go back to reference Fitzgerald RL, Fishel CE, Bush LL (1993) Fatality due to recreational use of chlorodifluoromethane and chloropentafluoroethane. J Forensic Sci 38:477–483PubMed Fitzgerald RL, Fishel CE, Bush LL (1993) Fatality due to recreational use of chlorodifluoromethane and chloropentafluoroethane. J Forensic Sci 38:477–483PubMed
43.
go back to reference Turkoglu C, Aliyev F, Celiker C, Uzunhasan I, Kocas C (2010) Slow heart-slow brain: consequence of short-term occupational exposure to toluene in a young woman: what is the real mechanism? Clin Cardiol 33:E68–E71PubMed Turkoglu C, Aliyev F, Celiker C, Uzunhasan I, Kocas C (2010) Slow heart-slow brain: consequence of short-term occupational exposure to toluene in a young woman: what is the real mechanism? Clin Cardiol 33:E68–E71PubMed
44.
go back to reference Sterman AB, Coyle PK (1983) Subacute toxic delirium following nitrous oxide abuse. Arch Neurol 40:446–447PubMed Sterman AB, Coyle PK (1983) Subacute toxic delirium following nitrous oxide abuse. Arch Neurol 40:446–447PubMed
45.
go back to reference Harris D, Mirza Z (2005) Butane encephalopathy. Emerg Med J 22:676–677PubMed Harris D, Mirza Z (2005) Butane encephalopathy. Emerg Med J 22:676–677PubMed
46.
go back to reference Kile SJ, Camilleri CC, Latchaw RE, Tharp BR (2006) Bithalamic lesions of butane encephalopathy. Pediatr Neurol 35:439–441PubMed Kile SJ, Camilleri CC, Latchaw RE, Tharp BR (2006) Bithalamic lesions of butane encephalopathy. Pediatr Neurol 35:439–441PubMed
47.
go back to reference Doring G, Baumeister FA, Peters J, von der Beek J (2002) Butane abuse associated encephalopathy. Klinische Padiatr 214:295–298 Doring G, Baumeister FA, Peters J, von der Beek J (2002) Butane abuse associated encephalopathy. Klinische Padiatr 214:295–298
48.
go back to reference Feuillet L, Mallet S, Spadari M (2006) Twin girls with neurocutaneous symptoms caused by mothball intoxication. N Engl J Med 355:423–424PubMed Feuillet L, Mallet S, Spadari M (2006) Twin girls with neurocutaneous symptoms caused by mothball intoxication. N Engl J Med 355:423–424PubMed
49.
go back to reference Kumar N, Dale LC, Wijdicks EF (2009) Mothball mayhem: relapsing toxic leukoencephalopathy due to p-dichlorobenzene neurotoxicity. Ann Intern Med 150:362–363PubMed Kumar N, Dale LC, Wijdicks EF (2009) Mothball mayhem: relapsing toxic leukoencephalopathy due to p-dichlorobenzene neurotoxicity. Ann Intern Med 150:362–363PubMed
50.
go back to reference Reygagne A, Garnier R, Chataigner D, Echenne B, Efthymiou ML (1992) Encephalopathy due to repeated voluntary inhalation of paradichlorobenzene. Journal De Toxicologie Clinique Et Experimentale 12:247–250PubMed Reygagne A, Garnier R, Chataigner D, Echenne B, Efthymiou ML (1992) Encephalopathy due to repeated voluntary inhalation of paradichlorobenzene. Journal De Toxicologie Clinique Et Experimentale 12:247–250PubMed
51.
go back to reference Hernandez SH, Wiener SW, Smith SW (2010) Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy. J Med Toxicol 6:217–229PubMedCentralPubMed Hernandez SH, Wiener SW, Smith SW (2010) Case files of the New York City poison control center: paradichlorobenzene-induced leukoencephalopathy. J Med Toxicol 6:217–229PubMedCentralPubMed
52.
go back to reference Peyravi M, Mirzayan MJ, Krauss JK (2012) Fatal outcome despite bilateral decompressive craniectomy for refractory intracranial pressure increase in butane intoxication. Clin Neurol Neurosurg 114:392–393PubMed Peyravi M, Mirzayan MJ, Krauss JK (2012) Fatal outcome despite bilateral decompressive craniectomy for refractory intracranial pressure increase in butane intoxication. Clin Neurol Neurosurg 114:392–393PubMed
53.
go back to reference D”Costa DF, Gunasekera NP (1990) Fatal cerebral oedema following trichloroethane abuse. J Royal Soc Med 83:533–534 D”Costa DF, Gunasekera NP (1990) Fatal cerebral oedema following trichloroethane abuse. J Royal Soc Med 83:533–534
54.
go back to reference Mutez E, Le Rhun E, Perriol MP et al (2006) Trichloroethylene intoxication presenting with temporal seizures. Rev Neurol 162:1248–1251PubMed Mutez E, Le Rhun E, Perriol MP et al (2006) Trichloroethylene intoxication presenting with temporal seizures. Rev Neurol 162:1248–1251PubMed
55.
go back to reference Rutchik JS, Wittman RI (2004) Neurologic issues with solvents. Clinics in occupational and environmental medicine 4:621–56 Rutchik JS, Wittman RI (2004) Neurologic issues with solvents. Clinics in occupational and environmental medicine 4:621–56
56.
go back to reference Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P (2002) Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol 40:21–34PubMed Rosenberg NL, Grigsby J, Dreisbach J, Busenbark D, Grigsby P (2002) Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol 40:21–34PubMed
57.
go back to reference Takagi M, Yucel M, Cotton SM et al (2011) Verbal memory, learning, and executive functioning among adolescent inhalant and cannabis users. J Stud Alcohol drugs 72:96–105PubMed Takagi M, Yucel M, Cotton SM et al (2011) Verbal memory, learning, and executive functioning among adolescent inhalant and cannabis users. J Stud Alcohol drugs 72:96–105PubMed
58.
go back to reference Dingwall KM, Cairney S (2011) Recovery from central nervous system changes following volatile substance misuse. Subst Use Misuse 46:73–83PubMed Dingwall KM, Cairney S (2011) Recovery from central nervous system changes following volatile substance misuse. Subst Use Misuse 46:73–83PubMed
59.
go back to reference Cairney S, Maruff P, Burns CB, Currie J, Currie BJ (2005) Neurological and cognitive recovery following abstinence from petrol sniffing. Neuropsychopharmacology 30:1019–1027PubMed Cairney S, Maruff P, Burns CB, Currie J, Currie BJ (2005) Neurological and cognitive recovery following abstinence from petrol sniffing. Neuropsychopharmacology 30:1019–1027PubMed
60.
go back to reference Hormes JT, Filley CM, Rosenberg NL (1986) Neurologic sequelae of chronic solvent vapor abuse. Neurology 36:698–702PubMed Hormes JT, Filley CM, Rosenberg NL (1986) Neurologic sequelae of chronic solvent vapor abuse. Neurology 36:698–702PubMed
61.
go back to reference Lloyd MJ, Fraunfelder FW (2007) Drug-induced optic neuropathies. Drugs Today 43:827–836PubMed Lloyd MJ, Fraunfelder FW (2007) Drug-induced optic neuropathies. Drugs Today 43:827–836PubMed
62.
go back to reference Twardowschy CA, Teive HA, Siquineli F et al (2008) Optic neuritis due to solvent abuse. Arquivos de neuro-psiquiatria 66:108–110PubMed Twardowschy CA, Teive HA, Siquineli F et al (2008) Optic neuritis due to solvent abuse. Arquivos de neuro-psiquiatria 66:108–110PubMed
63.
go back to reference Tamrazi B, Almast J (2012) Your brain on drugs: imaging of drug-related changes in the central nervous system. Radiographics 32:701–719PubMed Tamrazi B, Almast J (2012) Your brain on drugs: imaging of drug-related changes in the central nervous system. Radiographics 32:701–719PubMed
64.
go back to reference Borne J, Riascos R, Cuellar H, Vargas D, Rojas R (2005) Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging 16:239–245PubMed Borne J, Riascos R, Cuellar H, Vargas D, Rojas R (2005) Neuroimaging in drug and substance abuse part II: opioids and solvents. Top Magn Reson Imaging 16:239–245PubMed
65.
go back to reference Hashizume A, Koike H, Kawagashira Y et al (2011) Central nervous system involvement in n-hexane polyneuropathy demonstrated by MRI and proton MR spectroscopy. Clin Neurol Neurosurg 113:493–495PubMed Hashizume A, Koike H, Kawagashira Y et al (2011) Central nervous system involvement in n-hexane polyneuropathy demonstrated by MRI and proton MR spectroscopy. Clin Neurol Neurosurg 113:493–495PubMed
66.
go back to reference Robinson RO (1978) Tetraethyl lead poisoning from gasoline sniffing. JAMA 240:1373–1374PubMed Robinson RO (1978) Tetraethyl lead poisoning from gasoline sniffing. JAMA 240:1373–1374PubMed
67.
go back to reference Boeckx RL, Postl B, Coodin FJ (1978) Gasoline sniffing and tetraethyl lead poisoning in children. Pediatrics 60:140–145 Boeckx RL, Postl B, Coodin FJ (1978) Gasoline sniffing and tetraethyl lead poisoning in children. Pediatrics 60:140–145
68.
go back to reference Goodheart RS, Dunne JW (1994) Petrol sniffer’s encephalopathy. A study of 25 patients. Med J Aust 160:178–181PubMed Goodheart RS, Dunne JW (1994) Petrol sniffer’s encephalopathy. A study of 25 patients. Med J Aust 160:178–181PubMed
71.
go back to reference Tenenbein M (1997) Leaded gasoline abuse: the role of tetraethyl lead. Hum Exp Toxicol 16:217–222PubMed Tenenbein M (1997) Leaded gasoline abuse: the role of tetraethyl lead. Hum Exp Toxicol 16:217–222PubMed
72.
go back to reference King GS, Smialek JE, Troutman WG (1985) Sudden death in adolescents resulting from the inhalation of typewriter correction fluid. JAMA 253:1604–1606PubMed King GS, Smialek JE, Troutman WG (1985) Sudden death in adolescents resulting from the inhalation of typewriter correction fluid. JAMA 253:1604–1606PubMed
73.
go back to reference Smeeton WM, Clark MS (1985) Sudden death resulting from inhalation of fire extinguishers containing bromochlorodifluoromethane. Med Sci Law 25:258–262PubMed Smeeton WM, Clark MS (1985) Sudden death resulting from inhalation of fire extinguishers containing bromochlorodifluoromethane. Med Sci Law 25:258–262PubMed
74.
go back to reference Brady WJ Jr, Stremski E, Eljaiek L, Aufderheide TP (1994) Freon inhalational abuse presenting with ventricular fibrillation. Am J Emerg Med 12:533–536PubMed Brady WJ Jr, Stremski E, Eljaiek L, Aufderheide TP (1994) Freon inhalational abuse presenting with ventricular fibrillation. Am J Emerg Med 12:533–536PubMed
75.
go back to reference Rohrig TP (1997) Sudden death due to butane inhalation. The Am J Forensic Med Pathol 18:299–302 Rohrig TP (1997) Sudden death due to butane inhalation. The Am J Forensic Med Pathol 18:299–302
76.
go back to reference Williams DR, Cole SJ (1998) Ventricular fibrillation following butane gas inhalation. Resuscitation 37:43–45PubMed Williams DR, Cole SJ (1998) Ventricular fibrillation following butane gas inhalation. Resuscitation 37:43–45PubMed
77.
go back to reference Sugie H, Sasaki C, Hashimoto C et al (2004) Three cases of sudden death due to butane or propane gas inhalation: analysis of tissues for gas components. Forensic Sci Int 143:211–214PubMed Sugie H, Sasaki C, Hashimoto C et al (2004) Three cases of sudden death due to butane or propane gas inhalation: analysis of tissues for gas components. Forensic Sci Int 143:211–214PubMed
78.
go back to reference Rieder-Scharinger J, Peer R, Rabl W, Hasibeder W, Schobersberger W (2000) Multiple organ failure following inhalation of butane gas: a case report. Wien Klin Wochenschr 112:1049–1052PubMed Rieder-Scharinger J, Peer R, Rabl W, Hasibeder W, Schobersberger W (2000) Multiple organ failure following inhalation of butane gas: a case report. Wien Klin Wochenschr 112:1049–1052PubMed
79.
go back to reference LoVecchio F, Fulton SE (2001) Ventricular fibrillation following inhalation of Glade Air Freshener. Eur J Emerg Med 8:153–154PubMed LoVecchio F, Fulton SE (2001) Ventricular fibrillation following inhalation of Glade Air Freshener. Eur J Emerg Med 8:153–154PubMed
80.
go back to reference Girard F, Le Tacon S, Maria M, Pierrard O, Monin P (2008) Ventricular fibrillation following deodorant spray inhalation. Annales francaises d”anesthesie et de reanimation 27:83–85 Girard F, Le Tacon S, Maria M, Pierrard O, Monin P (2008) Ventricular fibrillation following deodorant spray inhalation. Annales francaises d”anesthesie et de reanimation 27:83–85
81.
go back to reference Godlewski K, Werner B, Sterlinski M et al (2006) Myocardial infarction after butane inhalation in a 14-year-old boy. Kardiologia polska 64:305–308PubMed Godlewski K, Werner B, Sterlinski M et al (2006) Myocardial infarction after butane inhalation in a 14-year-old boy. Kardiologia polska 64:305–308PubMed
82.
go back to reference De Naeyer AH, de Kort SW, Portegies MC, Deraedt DJ, Buysse CM (2011) Myocardial infarction in a 16-year old following inhalation of butane gas. Ned Tijdschr Geneeskd 155:A3443PubMed De Naeyer AH, de Kort SW, Portegies MC, Deraedt DJ, Buysse CM (2011) Myocardial infarction in a 16-year old following inhalation of butane gas. Ned Tijdschr Geneeskd 155:A3443PubMed
83.
go back to reference Edwards KE, Wenstone R (2000) Successful resuscitation from recurrent ventricular fibrillation secondary to butane inhalation. Br J Anaesth 84:803–805PubMed Edwards KE, Wenstone R (2000) Successful resuscitation from recurrent ventricular fibrillation secondary to butane inhalation. Br J Anaesth 84:803–805PubMed
84.
go back to reference Woods DT, Perry AW, Solomou S (2012) The neuropsychological sequelae of a 14-year-old girl following successful resuscitation from ventricular fibrillation and collapse secondary to butane gas inhalation. Resuscitation 83:e214–e215PubMed Woods DT, Perry AW, Solomou S (2012) The neuropsychological sequelae of a 14-year-old girl following successful resuscitation from ventricular fibrillation and collapse secondary to butane gas inhalation. Resuscitation 83:e214–e215PubMed
85.
go back to reference Dodd DE, Vinegar A (1998) Cardiac sensitization testing of the halon replacement candidates trifluoroiodomethane (CF3I) and 1,1,2,2,3,3,3-heptafluoro-1-iodopropane (C3F7I). Drug Chem Toxicol 21:137–149PubMed Dodd DE, Vinegar A (1998) Cardiac sensitization testing of the halon replacement candidates trifluoroiodomethane (CF3I) and 1,1,2,2,3,3,3-heptafluoro-1-iodopropane (C3F7I). Drug Chem Toxicol 21:137–149PubMed
86.
go back to reference Reinhardt CF, Mullin LS, Maxfield ME (1973) Epinephrine-induced cardiac arrhythmia potential of some common industrial solvents. J Occup Med 15:953–955PubMed Reinhardt CF, Mullin LS, Maxfield ME (1973) Epinephrine-induced cardiac arrhythmia potential of some common industrial solvents. J Occup Med 15:953–955PubMed
87.
go back to reference Alper AT, Akyol A, Hasdemir H et al (2008) Glue (toluene) abuse: increased QT dispersion and relation with unexplained syncope. Inhal Toxicol 20:37–41PubMed Alper AT, Akyol A, Hasdemir H et al (2008) Glue (toluene) abuse: increased QT dispersion and relation with unexplained syncope. Inhal Toxicol 20:37–41PubMed
88.
go back to reference Ueda H, Hayashi T, Tsumura K et al (2007) QT dispersion and prognosis after coronary stent placement in acute myocardial infarction. Clin Cardiol 30:229–233PubMed Ueda H, Hayashi T, Tsumura K et al (2007) QT dispersion and prognosis after coronary stent placement in acute myocardial infarction. Clin Cardiol 30:229–233PubMed
89.
go back to reference Lin YL, Hsiao CL, Wu YC, Kung MF (2011) Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes. J Clin Pharmacol 51:819–829PubMed Lin YL, Hsiao CL, Wu YC, Kung MF (2011) Electrophysiologic, pharmacokinetic, and pharmacodynamic values indicating a higher risk of torsades de pointes. J Clin Pharmacol 51:819–829PubMed
90.
go back to reference Himmel HM (2008) Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons? Crit Rev Toxicol 38:773–803PubMed Himmel HM (2008) Mechanisms involved in cardiac sensitization by volatile anesthetics: general applicability to halogenated hydrocarbons? Crit Rev Toxicol 38:773–803PubMed
91.
go back to reference Cruz SL, Orta-Salazar G, Gauthereau MY, Millan-Perez Pena L, Salinas-Stefanon EM (2003) Inhibition of cardiac sodium currents by toluene exposure. Br J Pharmacol 140:653–660PubMed Cruz SL, Orta-Salazar G, Gauthereau MY, Millan-Perez Pena L, Salinas-Stefanon EM (2003) Inhibition of cardiac sodium currents by toluene exposure. Br J Pharmacol 140:653–660PubMed
92.
go back to reference El-Menyar AA, El-Tawil M, Al Suwaidi J (2005) A teenager with angiographically normal epicardial coronary arteries and acute myocardial infarction after butane inhalation. Eur J Emerg Med 12:137–141PubMed El-Menyar AA, El-Tawil M, Al Suwaidi J (2005) A teenager with angiographically normal epicardial coronary arteries and acute myocardial infarction after butane inhalation. Eur J Emerg Med 12:137–141PubMed
93.
go back to reference Samson R, Kado H, Chapman D (2012) Huffing-induced cardiomyopathy: a case report. Cardiovasc Toxicol 12:90–92PubMed Samson R, Kado H, Chapman D (2012) Huffing-induced cardiomyopathy: a case report. Cardiovasc Toxicol 12:90–92PubMed
94.
go back to reference Lisowska A, Skibinska E, Musial WJ (2004) Severe heart failure due to toxic cardiomyopathy in a young patient—a case report. Kardiologia polska 60:372–373PubMed Lisowska A, Skibinska E, Musial WJ (2004) Severe heart failure due to toxic cardiomyopathy in a young patient—a case report. Kardiologia polska 60:372–373PubMed
95.
go back to reference Vural M, Ogel K (2006) Dilated cardiomyopathy associated with toluene abuse. Cardiology 105:158–161PubMed Vural M, Ogel K (2006) Dilated cardiomyopathy associated with toluene abuse. Cardiology 105:158–161PubMed
96.
go back to reference Steffee CH, Davis GJ, Nicol KK (1996) A whiff of death: fatal volatile solvent inhalation abuse. Southern Med J 89:879–884PubMed Steffee CH, Davis GJ, Nicol KK (1996) A whiff of death: fatal volatile solvent inhalation abuse. Southern Med J 89:879–884PubMed
97.
go back to reference McLeod AA, Marjot R, Monaghan MJ, Hugh-Jones P, Jackson G (1987) Chronic cardiac toxicity after inhalation of 1,1,1-trichloroethane. Br Med J (Clin Res Ed) 294:727–729 McLeod AA, Marjot R, Monaghan MJ, Hugh-Jones P, Jackson G (1987) Chronic cardiac toxicity after inhalation of 1,1,1-trichloroethane. Br Med J (Clin Res Ed) 294:727–729
98.
go back to reference Pfeiffer H, Al Khaddam M, Brinkmann B, Kohler H, Beike J (2006) Sudden death after isobutane sniffing: a report of two forensic cases. Int J Legal Med 120:168–173PubMed Pfeiffer H, Al Khaddam M, Brinkmann B, Kohler H, Beike J (2006) Sudden death after isobutane sniffing: a report of two forensic cases. Int J Legal Med 120:168–173PubMed
99.
go back to reference Phatak DR, Walterscheid J (2012) Huffing air conditioner fluid: a cool way to die? The Am J Forensic Med Pathol 33:64–67 Phatak DR, Walterscheid J (2012) Huffing air conditioner fluid: a cool way to die? The Am J Forensic Med Pathol 33:64–67
100.
go back to reference Heyer EJ, Simpson DM, Bodis-Wollner I, Diamond SP (1986) Nitrous oxide: clinical and electrophysiologic investigation of neurologic complications. Neurology 36:1618–1622PubMed Heyer EJ, Simpson DM, Bodis-Wollner I, Diamond SP (1986) Nitrous oxide: clinical and electrophysiologic investigation of neurologic complications. Neurology 36:1618–1622PubMed
101.
go back to reference Layzer RB (1978) Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 2:1227–1230PubMed Layzer RB (1978) Myeloneuropathy after prolonged exposure to nitrous oxide. Lancet 2:1227–1230PubMed
102.
go back to reference Shimizu T, Nishimura Y, Fujishima Y, Miyajima H, Honda N (1989) Subacute myeloneuropathy after abuse of nitrous oxide: an electron microscopic study on the peripheral nerve. Clinical Neurol 29:1129–1135 Shimizu T, Nishimura Y, Fujishima Y, Miyajima H, Honda N (1989) Subacute myeloneuropathy after abuse of nitrous oxide: an electron microscopic study on the peripheral nerve. Clinical Neurol 29:1129–1135
103.
go back to reference Blanco G, Peters HA (1983) Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol 40:416–418PubMed Blanco G, Peters HA (1983) Myeloneuropathy and macrocytosis associated with nitrous oxide abuse. Arch Neurol 40:416–418PubMed
104.
go back to reference Drummond JT, Matthews RG (1994) Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: characterization of the damage to the enzyme and prosthetic group. Biochemistry 33:3742–3750PubMed Drummond JT, Matthews RG (1994) Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: characterization of the damage to the enzyme and prosthetic group. Biochemistry 33:3742–3750PubMed
105.
go back to reference Ghobrial GM, Dalyai R, Flanders AE, Harrop J (2012) Nitrous oxide myelopathy posing as spinal cord injury. J Neurosurg Spine 16:489–491PubMed Ghobrial GM, Dalyai R, Flanders AE, Harrop J (2012) Nitrous oxide myelopathy posing as spinal cord injury. J Neurosurg Spine 16:489–491PubMed
106.
go back to reference Butzkueven H, King JO (2000) Nitrous oxide myelopathy in an abuser of whipped cream bulbs. J Clin Neurosci 7:73–75PubMed Butzkueven H, King JO (2000) Nitrous oxide myelopathy in an abuser of whipped cream bulbs. J Clin Neurosci 7:73–75PubMed
107.
go back to reference Krajewski W, Kucharska M, Pilacik B et al (2007) Impaired vitamin B12 metabolic status in healthcare workers occupationally exposed to nitrous oxide. Br J Anaesth 99:812–818PubMed Krajewski W, Kucharska M, Pilacik B et al (2007) Impaired vitamin B12 metabolic status in healthcare workers occupationally exposed to nitrous oxide. Br J Anaesth 99:812–818PubMed
108.
go back to reference Lin RJ, Chen HF, Chang YC, Su JJ (2011) Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurologica Taiwanica 20:129–137PubMed Lin RJ, Chen HF, Chang YC, Su JJ (2011) Subacute combined degeneration caused by nitrous oxide intoxication: case reports. Acta Neurologica Taiwanica 20:129–137PubMed
109.
go back to reference Senol MG, Sonmez G, Ozdag F, Saracoglu M (2008) Reversible myelopathy with vitamin B12 deficiency. Singap Med J 49:e330–e332 Senol MG, Sonmez G, Ozdag F, Saracoglu M (2008) Reversible myelopathy with vitamin B12 deficiency. Singap Med J 49:e330–e332
110.
go back to reference Srikanth SG, Jayakumar PN, Vasudev MK, Taly AB, Chandrashekar HS MRI in subacute combined degeneration of spinal cord: a case report and review of literature. Neurology India 50:310–2 Srikanth SG, Jayakumar PN, Vasudev MK, Taly AB, Chandrashekar HS MRI in subacute combined degeneration of spinal cord: a case report and review of literature. Neurology India 50:310–2
111.
go back to reference Kuwabara S, Kai MR, Nagase H, Hattori T (1999) n-Hexane neuropathy caused by addictive inhalation: clinical and electrophysiological features. Eur Neurol 41:163–167PubMed Kuwabara S, Kai MR, Nagase H, Hattori T (1999) n-Hexane neuropathy caused by addictive inhalation: clinical and electrophysiological features. Eur Neurol 41:163–167PubMed
112.
go back to reference Smith AG, Albers JW (1997) n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve 20:1445–1450PubMed Smith AG, Albers JW (1997) n-Hexane neuropathy due to rubber cement sniffing. Muscle Nerve 20:1445–1450PubMed
113.
go back to reference Hall DM, Ramsey J, Schwartz MS, Dookun D (1986) Neuropathy in a petrol sniffer. Arch Dis Child 61:900–901PubMed Hall DM, Ramsey J, Schwartz MS, Dookun D (1986) Neuropathy in a petrol sniffer. Arch Dis Child 61:900–901PubMed
114.
go back to reference Tenenbein M, deGroot W, Rajani KR (1984) Peripheral neuropathy following intentional inhalation of naphtha fumes. Can Med Assoc J 131:1077–1079PubMedCentralPubMed Tenenbein M, deGroot W, Rajani KR (1984) Peripheral neuropathy following intentional inhalation of naphtha fumes. Can Med Assoc J 131:1077–1079PubMedCentralPubMed
115.
go back to reference Altenkirch H, Mager J, Stoltenburg G, Helmbrecht J (1997) Toxic polyneuropathies after sniffing a glue thinner. J Neurol 214:137–152 Altenkirch H, Mager J, Stoltenburg G, Helmbrecht J (1997) Toxic polyneuropathies after sniffing a glue thinner. J Neurol 214:137–152
116.
go back to reference Korobkin R, Asbury AK, Sumner AJ, Nielsen SL (1975) Glue-sniffing neuropathy. Arch Neurol 32:158–162PubMed Korobkin R, Asbury AK, Sumner AJ, Nielsen SL (1975) Glue-sniffing neuropathy. Arch Neurol 32:158–162PubMed
117.
go back to reference Chang AP, England JD, Garcia CA, Sumner AJ (1998) Focal conduction block in n-hexane polyneuropathy. Muscle Nerve 21:964–969PubMed Chang AP, England JD, Garcia CA, Sumner AJ (1998) Focal conduction block in n-hexane polyneuropathy. Muscle Nerve 21:964–969PubMed
118.
go back to reference Huang CC (2008) Polyneuropathy induced by n-hexane intoxication in Taiwan. Acta Neurologica Taiwan 17:3–10 Huang CC (2008) Polyneuropathy induced by n-hexane intoxication in Taiwan. Acta Neurologica Taiwan 17:3–10
119.
go back to reference Weintraub E, Gandhi D, Robinson C (2000) Medical complications due to mothball abuse. South MedJ 93:427–429 Weintraub E, Gandhi D, Robinson C (2000) Medical complications due to mothball abuse. South MedJ 93:427–429
120.
go back to reference Szlatenyi CS, Wang RY (1996) Encephalopathy and cranial nerve palsies caused by intentional trichloroethylene inhalation. Am J Emerg Med 14:464–466PubMed Szlatenyi CS, Wang RY (1996) Encephalopathy and cranial nerve palsies caused by intentional trichloroethylene inhalation. Am J Emerg Med 14:464–466PubMed
121.
go back to reference Garrel S, Barret L (1986) Somatosensory evoked potentials of the trigeminal nerve in chronic trichloroethylene poisoning. Revue D”electroencephalographie Et De Neurophysiologie Clinique 16:133–139 Garrel S, Barret L (1986) Somatosensory evoked potentials of the trigeminal nerve in chronic trichloroethylene poisoning. Revue D”electroencephalographie Et De Neurophysiologie Clinique 16:133–139
122.
go back to reference Annau Z (1981) The neurobehavioral toxicity of trichloroethylene. Neurobehav Toxicol Teratol 3:417–424PubMed Annau Z (1981) The neurobehavioral toxicity of trichloroethylene. Neurobehav Toxicol Teratol 3:417–424PubMed
123.
go back to reference Ehyai A, Freemon FR (1983) Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry 46:349–351PubMed Ehyai A, Freemon FR (1983) Progressive optic neuropathy and sensorineural hearing loss due to chronic glue sniffing. J Neurol Neurosurg Psychiatry 46:349–351PubMed
124.
go back to reference Williams DM (1988) Hearing loss in a glue sniffer. J Otolaryngol 17:321–324PubMed Williams DM (1988) Hearing loss in a glue sniffer. J Otolaryngol 17:321–324PubMed
125.
go back to reference Buker HS, Demir E, Yuncu Z, Gulen F, Midyat L, Tanac R (2011) Effects of volatile substance abuse on the respiratory system in adolescents. Multidisciplinary Respiratory Medicine 6:161–168PubMedCentralPubMed Buker HS, Demir E, Yuncu Z, Gulen F, Midyat L, Tanac R (2011) Effects of volatile substance abuse on the respiratory system in adolescents. Multidisciplinary Respiratory Medicine 6:161–168PubMedCentralPubMed
127.
go back to reference Cayir D, Demirel K, Korkmaz M, Koca G (2011) Evaluation of lung epithelial permeability in the volatile substance abuse using Tc-99m DTPA aerosol scintigraphy. Ann Nucl Med 25:554–559PubMed Cayir D, Demirel K, Korkmaz M, Koca G (2011) Evaluation of lung epithelial permeability in the volatile substance abuse using Tc-99m DTPA aerosol scintigraphy. Ann Nucl Med 25:554–559PubMed
128.
go back to reference Sundram FX (1995) Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol. Ann Nucl Med 9:171–178PubMed Sundram FX (1995) Clinical studies of alveolar-capillary permeability using technetium-99m DTPA aerosol. Ann Nucl Med 9:171–178PubMed
129.
go back to reference Burkhart KK, Britt A, Petrini G, O”Donnell S, Donovan JW (1996) Pulmonary toxicity following exposure to an aerosolized leather protector. J Toxicol Clin Toxicol 34:21–24PubMed Burkhart KK, Britt A, Petrini G, O”Donnell S, Donovan JW (1996) Pulmonary toxicity following exposure to an aerosolized leather protector. J Toxicol Clin Toxicol 34:21–24PubMed
130.
go back to reference Shah MK (2002) Outcomes in patients with Goodpasture’s syndrome and hydrocarbon exposure. Ren Fail 24:545–555PubMed Shah MK (2002) Outcomes in patients with Goodpasture’s syndrome and hydrocarbon exposure. Ren Fail 24:545–555PubMed
131.
go back to reference Schloneger M, Stull A, Singer JI. Inhalant abuse: a case of hemoptysis associated with halogenated hydrocarbons abuse. Pediatr Emerg Care 25:754–7 Schloneger M, Stull A, Singer JI. Inhalant abuse: a case of hemoptysis associated with halogenated hydrocarbons abuse. Pediatr Emerg Care 25:754–7
132.
go back to reference Kurniali PC, Henry L, Kurl R, Meharg JV (2012) Inhalant abuse of computer cleaner manifested as angioedema. Am J Emerg Med 30(265):e3–e5PubMed Kurniali PC, Henry L, Kurl R, Meharg JV (2012) Inhalant abuse of computer cleaner manifested as angioedema. Am J Emerg Med 30(265):e3–e5PubMed
133.
go back to reference Kuspis DA, Krenzelok EP (1999) Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon. J Toxicol Clin Toxicol 37:873–875PubMed Kuspis DA, Krenzelok EP (1999) Oral frostbite injury from intentional abuse of a fluorinated hydrocarbon. J Toxicol Clin Toxicol 37:873–875PubMed
134.
go back to reference Albright JT, Lebovitz BL, Lipson R, Luft J (1999) Upper aerodigestive tract frostbite complicating volatile substance abuse. Int J Pediatr Otorhinolaryngol 49:63–67PubMed Albright JT, Lebovitz BL, Lipson R, Luft J (1999) Upper aerodigestive tract frostbite complicating volatile substance abuse. Int J Pediatr Otorhinolaryngol 49:63–67PubMed
135.
go back to reference Kurbat RS, Pollack CV Jr (1998) Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med 16:167–169PubMed Kurbat RS, Pollack CV Jr (1998) Facial injury and airway threat from inhalant abuse: a case report. J Emerg Med 16:167–169PubMed
136.
go back to reference Elliott DC (1991) Frostbite of the mouth: a case report. Military Medicine 156:18–19PubMed Elliott DC (1991) Frostbite of the mouth: a case report. Military Medicine 156:18–19PubMed
137.
go back to reference Weber LW, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136PubMed Weber LW, Boll M, Stampfl A (2003) Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–136PubMed
138.
go back to reference McIntyre AS, Long RG (1992) Fatal fulminant hepatic failure in a “solvent abuser”. Postgrad Med J 68:29–30PubMed McIntyre AS, Long RG (1992) Fatal fulminant hepatic failure in a “solvent abuser”. Postgrad Med J 68:29–30PubMed
139.
go back to reference Beisland HO, Wannag SA (1970) Trichloroethylene sniffing. Acute liver and kidney damage. Tidsskrift for den Norske laegeforening 90:285–288PubMed Beisland HO, Wannag SA (1970) Trichloroethylene sniffing. Acute liver and kidney damage. Tidsskrift for den Norske laegeforening 90:285–288PubMed
140.
go back to reference Clearfield HR (1970) Hepatorenal toxicity from sniffing spot-remover (trichloroethylene). Report of 2 cases. Am J Dig Dis 15:851–856PubMed Clearfield HR (1970) Hepatorenal toxicity from sniffing spot-remover (trichloroethylene). Report of 2 cases. Am J Dig Dis 15:851–856PubMed
141.
go back to reference Takaki A, Suzuki H, Iwasaki Y et al (2008) A 27-year-old man who died of acute liver failure probably due to trichloroethylene abuse. J Gastroenterol 43:239–242PubMed Takaki A, Suzuki H, Iwasaki Y et al (2008) A 27-year-old man who died of acute liver failure probably due to trichloroethylene abuse. J Gastroenterol 43:239–242PubMed
142.
go back to reference Ramdhan DH, Kamijima M, Yamada N et al (2008) Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1. Toxicol Appl Pharmacol 231:300–307PubMed Ramdhan DH, Kamijima M, Yamada N et al (2008) Molecular mechanism of trichloroethylene-induced hepatotoxicity mediated by CYP2E1. Toxicol Appl Pharmacol 231:300–307PubMed
143.
go back to reference Batlle DC, Sabatini S, Kurtzman NA (1988) On the mechanism of toluene-induced renal tubular acidosis. Nephron 49:210–218PubMed Batlle DC, Sabatini S, Kurtzman NA (1988) On the mechanism of toluene-induced renal tubular acidosis. Nephron 49:210–218PubMed
144.
go back to reference Dickson RP, Luks AM (2009) Toluene toxicity as a cause of elevated anion gap metabolic acidosis. Respir Care 54:1115–1117PubMed Dickson RP, Luks AM (2009) Toluene toxicity as a cause of elevated anion gap metabolic acidosis. Respir Care 54:1115–1117PubMed
145.
go back to reference Erramouspe J, Galvez R, Fischel DR (1996) Newborn renal tubular acidosis associated with prenatal maternal toluene sniffing. J Psychoactive Drugs 28:201–204PubMed Erramouspe J, Galvez R, Fischel DR (1996) Newborn renal tubular acidosis associated with prenatal maternal toluene sniffing. J Psychoactive Drugs 28:201–204PubMed
146.
go back to reference Lock EA, Reed CJ (2006) Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment. Toxicol Sci 91:313–331PubMed Lock EA, Reed CJ (2006) Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment. Toxicol Sci 91:313–331PubMed
147.
go back to reference Dubosq F, Linke C, Cardot V, Meria P, Desgrandchamps F, Teillac P (2005) Renal cell carcinoma and trichloroethylene. Progres en urologie 15:525–528PubMed Dubosq F, Linke C, Cardot V, Meria P, Desgrandchamps F, Teillac P (2005) Renal cell carcinoma and trichloroethylene. Progres en urologie 15:525–528PubMed
148.
go back to reference Wilkerson RG (2010) Getting the blues at a rock concert: a case of severe methaemoglobinaemia. Emerg Med Australas 22:466–469PubMed Wilkerson RG (2010) Getting the blues at a rock concert: a case of severe methaemoglobinaemia. Emerg Med Australas 22:466–469PubMed
149.
go back to reference Modarai B, Kapadia YK, Kerins M, Terris J (2002) Methylene blue: a treatment for severe methaemoglobinaemia secondary to misuse of amyl nitrite. Emerg Med J 19:270–271PubMed Modarai B, Kapadia YK, Kerins M, Terris J (2002) Methylene blue: a treatment for severe methaemoglobinaemia secondary to misuse of amyl nitrite. Emerg Med J 19:270–271PubMed
150.
go back to reference Edwards RJ, Ujma J (1995) Extreme methaemoglobinaemia secondary to recreational use of amyl nitrite. J Accid Emerg Med 12:138–142PubMedCentralPubMed Edwards RJ, Ujma J (1995) Extreme methaemoglobinaemia secondary to recreational use of amyl nitrite. J Accid Emerg Med 12:138–142PubMedCentralPubMed
151.
go back to reference Stambach T, Haire K, Soni N, Booth J (1997) Saturday night blue—a case of near fatal poisoning from the abuse of amyl nitrite. J Accid Emerg Med 14:339–340PubMedCentralPubMed Stambach T, Haire K, Soni N, Booth J (1997) Saturday night blue—a case of near fatal poisoning from the abuse of amyl nitrite. J Accid Emerg Med 14:339–340PubMedCentralPubMed
152.
go back to reference Praharaj SK, Kongasseri S (2012) Naphthalene Addict Subst Abus 33:189–190 Praharaj SK, Kongasseri S (2012) Naphthalene Addict Subst Abus 33:189–190
153.
go back to reference Valaes T, Doxiadis SA, Fessas P (1963) Acute hemolysis due to naphthalene inhalation. J Pediatr 63:904–915PubMed Valaes T, Doxiadis SA, Fessas P (1963) Acute hemolysis due to naphthalene inhalation. J Pediatr 63:904–915PubMed
154.
go back to reference Santucci K, Shah B (2000) Association of naphthalene with acute hemolytic anemia. Acad Emerg Med 7:42–47PubMed Santucci K, Shah B (2000) Association of naphthalene with acute hemolytic anemia. Acad Emerg Med 7:42–47PubMed
155.
go back to reference Athanasiou M, Tsantali C, Trachana M, Hatziioannides C (1997) Hemolytic anemia in a female newborn infant whose mother inhaled naphthalene before delivery. J Pediatr 130:680–681PubMed Athanasiou M, Tsantali C, Trachana M, Hatziioannides C (1997) Hemolytic anemia in a female newborn infant whose mother inhaled naphthalene before delivery. J Pediatr 130:680–681PubMed
156.
go back to reference Raphael M, Nadiras P, Flacke-Vordos N (2002) Acute methylene chloride intoxication—a case report on domestic poisoning. Eur J Emerg Med 9:57–59PubMed Raphael M, Nadiras P, Flacke-Vordos N (2002) Acute methylene chloride intoxication—a case report on domestic poisoning. Eur J Emerg Med 9:57–59PubMed
157.
go back to reference Horowitz BZ (1986) Carboxyhemoglobinemia caused by inhalation of methylene chloride. Am J Emerg Med 4:48–51PubMed Horowitz BZ (1986) Carboxyhemoglobinemia caused by inhalation of methylene chloride. Am J Emerg Med 4:48–51PubMed
158.
go back to reference Rioux JP, Myers RAM (1998) Methylene chloride poisoning: a paradigmatic review. J Emerg Med 6:227–238 Rioux JP, Myers RAM (1998) Methylene chloride poisoning: a paradigmatic review. J Emerg Med 6:227–238
159.
go back to reference Peckham T, Kopstein M, Klein J, Dahlgren J (2012), Benzene-contaminated toluene and acute myeloid leukemia: a case series and review of literature. Toxicology and industrial health. Epub ahead of print Jun 27, 2012 Peckham T, Kopstein M, Klein J, Dahlgren J (2012), Benzene-contaminated toluene and acute myeloid leukemia: a case series and review of literature. Toxicology and industrial health. Epub ahead of print Jun 27, 2012
160.
go back to reference Lasala BJ, Zaenglein AL (2012) Cutaneous and mucosal blistering secondary to "Huffing". Pediatr Dermatol. Epub September 4, 2012 Lasala BJ, Zaenglein AL (2012) Cutaneous and mucosal blistering secondary to "Huffing". Pediatr Dermatol. Epub September 4, 2012
161.
go back to reference Janezic TF (1997) Burns following petrol sniffing. Burns 23:78–80PubMed Janezic TF (1997) Burns following petrol sniffing. Burns 23:78–80PubMed
162.
go back to reference Ho WS, To EW, Chan ES, King WW (1998) Burn injuries during paint thinner sniffing. Burns 24:757–759PubMed Ho WS, To EW, Chan ES, King WW (1998) Burn injuries during paint thinner sniffing. Burns 24:757–759PubMed
163.
go back to reference Levine B (2003) Principles of forensic toxicology, 2nd edn. AACC, Washington, DC Levine B (2003) Principles of forensic toxicology, 2nd edn. AACC, Washington, DC
164.
go back to reference Wang RS, Nakajima T, Honma T (1999) Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. Toxicology 132:9–18PubMed Wang RS, Nakajima T, Honma T (1999) Trichloroethylene inhibits aldehyde dehydrogenase only for aliphatic aldehydes of short chains in rats. Toxicology 132:9–18PubMed
165.
go back to reference Bowen SE (2011) Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome. Subst Use Misuse 46(Suppl 1):68–72PubMed Bowen SE (2011) Two serious and challenging medical complications associated with volatile substance misuse: sudden sniffing death and fetal solvent syndrome. Subst Use Misuse 46(Suppl 1):68–72PubMed
166.
go back to reference Hersh JH, Podruch PE, Rogers G, Weisskopf B (1985) Toluene embryopathy. J Pediatr 106:922–927PubMed Hersh JH, Podruch PE, Rogers G, Weisskopf B (1985) Toluene embryopathy. J Pediatr 106:922–927PubMed
167.
go back to reference Hersh JH (1989) Toluene embryopathy: two new cases. J Med Genet 26:333–337PubMed Hersh JH (1989) Toluene embryopathy: two new cases. J Med Genet 26:333–337PubMed
168.
go back to reference Arai H, Yamada M, Miyake S et al (1997) Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome. Brain Dev 29:361–366 Arai H, Yamada M, Miyake S et al (1997) Two cases of toluene embryopathy with severe motor and intellectual disabilities syndrome. Brain Dev 29:361–366
169.
go back to reference Pearson MA, Hoyme HE, Seaver LH, Rimsza ME (1994) Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 93:211–215PubMed Pearson MA, Hoyme HE, Seaver LH, Rimsza ME (1994) Toluene embryopathy: delineation of the phenotype and comparison with fetal alcohol syndrome. Pediatrics 93:211–215PubMed
170.
go back to reference Ozmen S, Seckin N, Turhan NO, Dilmen G, Dilmen U (1995) Fetal methemoglobinemia: a cause of nonimmune hydrops fetalis. Am J Obstet Gynecol 173:232–233PubMed Ozmen S, Seckin N, Turhan NO, Dilmen G, Dilmen U (1995) Fetal methemoglobinemia: a cause of nonimmune hydrops fetalis. Am J Obstet Gynecol 173:232–233PubMed
171.
go back to reference Dodd J (2001) Petrol sniffing in a pregnant Aboriginal population: a review of maternal and neonatal outcomes. Aust N Z J Obstet Gynaecol 41:420–423PubMed Dodd J (2001) Petrol sniffing in a pregnant Aboriginal population: a review of maternal and neonatal outcomes. Aust N Z J Obstet Gynaecol 41:420–423PubMed
172.
go back to reference Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Archives of disease in childhood Fetal and neonatal edition. 74, F204-7 Tenenbein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Archives of disease in childhood Fetal and neonatal edition. 74, F204-7
173.
go back to reference Nee PA, Llewellyn T, Pritty PE (1990) Successful out-of-hospital defibrillation for ventricular fibrillation complicating solvent abuse. Arch Emerg Med 7:220–223PubMedCentralPubMed Nee PA, Llewellyn T, Pritty PE (1990) Successful out-of-hospital defibrillation for ventricular fibrillation complicating solvent abuse. Arch Emerg Med 7:220–223PubMedCentralPubMed
174.
go back to reference Senthilkumaran S, Meenakshisundaram R, Michaels AD, Balamurgan N, Thirumalaikolundusubramanian P (2012) Ventricular fibrillation after exposure to air freshener-death just a breath away. J Electrocardiol 45:164–166PubMed Senthilkumaran S, Meenakshisundaram R, Michaels AD, Balamurgan N, Thirumalaikolundusubramanian P (2012) Ventricular fibrillation after exposure to air freshener-death just a breath away. J Electrocardiol 45:164–166PubMed
175.
go back to reference Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ (1995) Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 92:3089–3093PubMed Tang W, Weil MH, Sun S, Noc M, Yang L, Gazmuri RJ (1995) Epinephrine increases the severity of postresuscitation myocardial dysfunction. Circulation 92:3089–3093PubMed
176.
go back to reference de Oliveira FC, Feitosa-Filho GS, Ritt LE (2012) Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review. Resuscitation 83:674–683PubMed de Oliveira FC, Feitosa-Filho GS, Ritt LE (2012) Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review. Resuscitation 83:674–683PubMed
177.
go back to reference Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM (2000) Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102:742–747PubMed Nademanee K, Taylor R, Bailey WE, Rieders DE, Kosar EM (2000) Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy. Circulation 102:742–747PubMed
178.
go back to reference Miwa Y, Ikeda T, Mera H et al (2010) Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 74:856–863PubMed Miwa Y, Ikeda T, Mera H et al (2010) Effects of landiolol, an ultra-short-acting beta1-selective blocker, on electrical storm refractory to class III antiarrhythmic drugs. Circ J 74:856–863PubMed
179.
go back to reference Wiest DB, Haney JS (2012) Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clin Pharmacokinet 51:347–356PubMed Wiest DB, Haney JS (2012) Clinical pharmacokinetics and therapeutic efficacy of esmolol. Clin Pharmacokinet 51:347–356PubMed
180.
go back to reference Burns CB, Currie B The efficacy of chelation therapy and factors influencing mortality in lead intoxicated petrol sniffers. Aust N Z J Med. 25:197–203 Burns CB, Currie B The efficacy of chelation therapy and factors influencing mortality in lead intoxicated petrol sniffers. Aust N Z J Med. 25:197–203
181.
go back to reference Skacel PO, Chanarin I, Hewlett A, Nunn JF (1982) Failure to correct nitrous oxide toxicity with folinic acid. Anesthesiology 57:557–558PubMed Skacel PO, Chanarin I, Hewlett A, Nunn JF (1982) Failure to correct nitrous oxide toxicity with folinic acid. Anesthesiology 57:557–558PubMed
182.
go back to reference Amos RJ, Amess JA, Nancekievill DG, Rees GM (1984) Prevention of nitrous oxide-induced megaloblastic changes in bone marrow using folinic acid. Br J Anaesth 56:103–107PubMed Amos RJ, Amess JA, Nancekievill DG, Rees GM (1984) Prevention of nitrous oxide-induced megaloblastic changes in bone marrow using folinic acid. Br J Anaesth 56:103–107PubMed
183.
go back to reference Nunn JF, Chanarin I, Tanner AG, Owen ER (1986) Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia. Reversal with folinic acid. Br J Anaesth 58:1469–1470PubMed Nunn JF, Chanarin I, Tanner AG, Owen ER (1986) Megaloblastic bone marrow changes after repeated nitrous oxide anaesthesia. Reversal with folinic acid. Br J Anaesth 58:1469–1470PubMed
184.
go back to reference Lee JH, Sung CH, Moon SH, Kim SN, Chung WH (1993) Folinic acid protection against hematopoietic depression induced by nitrous oxide in rats. Anesth Analg 77:356–361PubMed Lee JH, Sung CH, Moon SH, Kim SN, Chung WH (1993) Folinic acid protection against hematopoietic depression induced by nitrous oxide in rats. Anesth Analg 77:356–361PubMed
185.
go back to reference Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA (2002) American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 40:415–446PubMed Barceloux DG, Bond GR, Krenzelok EP, Cooper H, Vale JA (2002) American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. J Toxicol Clin Toxicol 40:415–446PubMed
186.
go back to reference Rioux JP, Myers RA (1988) Methylene chloride poisoning: a paradigmatic review. J Emerg Med 6:227–238PubMed Rioux JP, Myers RA (1988) Methylene chloride poisoning: a paradigmatic review. J Emerg Med 6:227–238PubMed
187.
go back to reference Rioux JP, Myers RA (1989) Hyperbaric oxygen for methylene chloride poisoning: report on two cases. Ann Emerg Med 18:691–695PubMed Rioux JP, Myers RA (1989) Hyperbaric oxygen for methylene chloride poisoning: report on two cases. Ann Emerg Med 18:691–695PubMed
188.
go back to reference Rudge FW (1990) Treatment of methylene chloride induced carbon monoxide poisoning with hyperbaric oxygenation. Military Med 155:570–572 Rudge FW (1990) Treatment of methylene chloride induced carbon monoxide poisoning with hyperbaric oxygenation. Military Med 155:570–572
189.
go back to reference Galicia-Moreno M, Rodriguez-Rivera A, Reyes-Gordillo K et al (2009) N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur J Gastroenterol Hepatol 21:908–914PubMed Galicia-Moreno M, Rodriguez-Rivera A, Reyes-Gordillo K et al (2009) N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur J Gastroenterol Hepatol 21:908–914PubMed
190.
go back to reference Gerkin RD Jr, LoVecchio F (1998) Rapid reversal of life-threatening toluene-induced hypokalemia with hemodialysis. J Emergency Med 16:723–725 Gerkin RD Jr, LoVecchio F (1998) Rapid reversal of life-threatening toluene-induced hypokalemia with hemodialysis. J Emergency Med 16:723–725
191.
go back to reference MacLean S, Cameron J, Harney A, Lee NK (2012) Psychosocial therapeutic interventions for volatile substance use: a systematic review. Addiction 107:278–288PubMed MacLean S, Cameron J, Harney A, Lee NK (2012) Psychosocial therapeutic interventions for volatile substance use: a systematic review. Addiction 107:278–288PubMed
Metadata
Title
Volatile Substance Misuse: An Updated Review of Toxicity and Treatment
Authors
Jonathan B. Ford
Mark E. Sutter
Kelly P. Owen
Timothy E. Albertson
Publication date
01-02-2014
Publisher
Springer US
Published in
Clinical Reviews in Allergy & Immunology / Issue 1/2014
Print ISSN: 1080-0549
Electronic ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-013-8371-1

Other articles of this Issue 1/2014

Clinical Reviews in Allergy & Immunology 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine